scholarly journals Renal scintigraphic captopril test in the diagnosis of renovascular hypertension.

Hypertension ◽  
1987 ◽  
Vol 10 (2) ◽  
pp. 212-220 ◽  
Author(s):  
E Fommei ◽  
S Ghione ◽  
L Palla ◽  
F Mosca ◽  
M Ferrari ◽  
...  
Author(s):  
B. Kutkuhn ◽  
E. Godehardt ◽  
J. Kunert ◽  
G. Torsello ◽  
B. Grabensee

Angiology ◽  
1992 ◽  
Vol 43 (11) ◽  
pp. 939-945
Author(s):  
J. Nortier ◽  
J.C. Wautrecht ◽  
C. Delcour ◽  
A. Schoutens ◽  
J.P. Dereume

1998 ◽  
Vol 116 (1) ◽  
pp. 1613-1617
Author(s):  
Fausto Miranda Jr. ◽  
Maria del Carmen Janeiro Perez ◽  
Frida Plavnik ◽  
João Francisco Jr. ◽  
Emil Burihan

OBJECTIVE: to evaluate the use of percutaneous transluminal renal angioplasty (PTRA) in the treatment of renal vascular hypertension. DESIGN: sequential prospective PTRA treatment of severe arterial hypertension, screening by the captopril test, confirmed by renal arteriography, and the result evaluated by post-PTRA arteriography, blood pressure measurement and renal function. SITE: Vascular Surgery, angioradiology sector, and Nephrology outpatients department of the Federal University of São Paulo - Paulista School of Medicine, São Paulo, Brazil, a tertiary health-care institution. PARTICIPANTS: PTRA was employed on 32 patients screened by clinical examination, captopril test and renal arteriography. EVALUATION: PTRA results were evaluated by the criteria of the Cooperative Study of Renovascular Hypertension. RESULTS: after PTRA the completion arteriography showed no renal stenosis in 24 patients (75%), residual stenosis (20-50%) in 3 (9.4%) and no change in 5 (15.6%). The blood pressure results were: 3 patients (9.4%) were cured, 24 (75%) improved: and 5 (15.6%) were unchanged. We observed normal renal function before and after PTRA in 25 patients (78%); altered pre- and improved post-PTRA in 2 (6.3%); post-PTRA remained unaltered in 2 (6.3%); and altered pre- and worsened post-PTRA in 3 (9.4%). Recurrence of stenosis occurred in one patient after 8 months. CONCLUSIONS: PTRA is a convenient procedure, relatively safe and an effective complementary method of medical therapy for controlling renovascular hypertension.


1993 ◽  
Vol 6 (11_Pt_1) ◽  
pp. 899-906 ◽  
Author(s):  
Taisuke Iwaoka ◽  
Teruhisa Umeda ◽  
Shojiro Naomi ◽  
Junnosuke Inoue ◽  
Masato Sasaki ◽  
...  

1994 ◽  
Vol 24 (4) ◽  
pp. 660-664 ◽  
Author(s):  
Richard A. Davidson ◽  
Yousri M. Barri ◽  
Christopher S. Wilcox

1991 ◽  
Vol 37 (10) ◽  
pp. 1831-1837 ◽  
Author(s):  
T G Pickering

Abstract The diagnosis of renovascular hypertension depends heavily on laboratory tests. There is no universally applicable screening test, and it should be actively sought only in patients with clinical clues suggested by the history, physical examination, and routine laboratory testing. Hyperreninemia is a characteristic finding, and acute blockade of the renin system forms the basis of diagnostic tests such as the oral captopril test and captopril renography. Other abnormal laboratory findings include hypokalemia, proteinuria, and azotemia exacerbated by angiotensin-converting enzyme inhibitors.


Sign in / Sign up

Export Citation Format

Share Document